Business Description
Halberd Corp
NAICS : 541714
SIC : 2834
ISIN : US4053311092
Description
Halberd Corp is a research-based biotechnology company seeking to discover and develop medical treatments for a range of diseases. The Company's extracorporeal treatment is designed to treat hard-to-cure blood-borne, neurologic and infectious diseases. The Company's patented methodology removes the appropriate bodily fluid from the patient, in a continuous fashion, like dialysis, or in a batch process, like blood sample testing.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.05 | |||||
Equity-to-Asset | -77.17 | |||||
Debt-to-Equity | -0.16 | |||||
Debt-to-EBITDA | -0.34 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -1002.39 | |||||
Beneish M-Score | -85.07 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 55.86 | |||||
9-Day RSI | 53.01 | |||||
14-Day RSI | 51.4 | |||||
6-1 Month Momentum % | 21.68 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.01 | |||||
Quick Ratio | 0.01 | |||||
Cash Ratio | 0.01 | |||||
Days Payable | 87508.75 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -4.8 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 33.33 | |||||
Operating Margin % | -14900 | |||||
Net Margin % | -15133.33 | |||||
FCF Margin % | -8033.33 | |||||
ROA % | -3131.03 | |||||
ROIC % | -12771.43 | |||||
ROC (Joel Greenblatt) % | -9933.33 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -12.27 | |||||
EV-to-EBITDA | -12.3 | |||||
EV-to-Revenue | 1828.33 | |||||
EV-to-FCF | -21.18 | |||||
Earnings Yield (Greenblatt) % | -8.15 | |||||
FCF Yield % | -4.36 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:HALB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Halberd Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.003 | ||
EPS (TTM) ($) | -0.001 | ||
Beta | 0.25 | ||
Volatility % | 113.64 | ||
14-Day RSI | 51.4 | ||
14-Day ATR ($) | 0.001367 | ||
20-Day SMA ($) | 0.008192 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 0.003 - 0.0122 | ||
Shares Outstanding (Mil) | 635.87 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Halberd Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Halberd Corp Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Halberd Corp Frequently Asked Questions
What is Halberd Corp(HALB)'s stock price today?
The current price of HALB is $0.01. The 52 week high of HALB is $0.01 and 52 week low is $0.00.
When is next earnings date of Halberd Corp(HALB)?
The next earnings date of Halberd Corp(HALB) is .
Does Halberd Corp(HALB) pay dividends? If so, how much?
Halberd Corp(HALB) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |